The new launch is expected to further increase Wattle Health’s brand awareness in the highly lucrative Chinese market and generate additional sales across its extensive distribution network in China.
The launch will also assist in sales of Wattle Health’s infant formula range in China, once it obtains the required license.
Wattle Health executive chairman Lazarus Karasavvidis said: “The addition of additional SKU’s available for general trade sale in China will further expand brand awareness and more importantly revenue.
“This is a continuation of our China market strategy and ongoing commitment to making healthy, pure 100% Australian made produce available to our China consumer and supporting our extensive distribution partners.”
READ: Wattle Health Australia delivers record sales as it broadens its product range and enters new markets
Wattle Health will be exhibiting products at one of China’s largest trade fair for child, baby and maternity products - Shanghai International Children Baby and Maternity Products Industry Expo (CBME) from July 25 to 27.
CBME attracts 88,000+ trade buyers and about 1,500 sessions of business matching meetings with buyers and business partners from large department stores, supermarkets, online retailers, chain stores and key distributors in China.
Wattle Health will be represented at CBME in its distinctive custom-built exhibition stand presenting its entire product suite for both general trade and cross border e-commerce sales.